Search |  Site map |  RUS |  ENG   
ABOUT RMBC
PRODUCTS AND SERVICES
ANALYTICAL
CLIENTS
MARKET RESEARCH SHOP
CONTACT US
USEFUL LINKS


Home / Market research shop

VI. SURVEY OF PHARMACISTS OF OTC DEPARTMENTS AND END CONSUMERS

Issue: nasal and expectorant drugs

Methodology: personal survey

Sample:
Respondents
City
Moscow
Saint-Petersburg
Perm
Pharmacists
150
90
50
End consumers
800
700
500

  • The required minimal number of retail stores in the sample is observed
  • Sample contains private and municipal/state unitary enterprises
  • Large chains are included
  • Pharmacies in different districts/areas
  • Respondents are split by sex:
    • Males - nearly 20%
    • Females - nearly 80%
  • Respondents are split by age:
    • 18-25 years - around 25%
    • 26-40 years - around 35%
    • 41-65 years - around 35%
    • 66-70 years - no more than 5%
  • Consumer survey is conducted in: pharmacy sales area, nearby territory and pharmacies located in shopping-malls

Analyzed period: August 2004

Format: Power Point

Language: Russian

Split by cities

Size: 97 slides (nasal preparations), 101 slides (expectorant preparation)

Slides:

Pharmacists Survey:

    1. Aided awareness of nasal/expectorant brands
    2. Most frequently recommended nasal/expectorant drugs (open question)
    3. Most frequently recommended nasal/expectorant drugs (open question):

    • for treatment of severe rhinitis/dry cough in adults
    • for treatment of stuffiness/moist cough in adults
    • for treatment of severe rhinitis/dry cough in children
    • for treatment of stuffiness/moist cough in children
    • for treatment of allergic rhinitis in adults/smoker's cough
    • for treatment of allergic rhinitis in children

    4. Key factors for choosing nasal/expectorant drugs (according to pharmacists)

End consumer survey

    1. Nasal/expectorant drugs known and used by consumers

    • Unaided awareness
    • Aided awareness
    • Drug used last time to treat rhinitis

    2. Reasons why consumers used nasal/expectorant drugs
    3. Number of dosage forms of nasal/expectorant drugs used by consumers
    4. Share of each dosage form of nasal/expectorant drugs used by consumers
    5. Nasal/expectorant drug dosage form preferred by consumers
    6. Reasons why consumers prefer a certain dosage form of nasal/expectorant drugs
    7. Reasons why consumers use a certain dosage form of nasal/expectorant drugs less often
    8. Reasons why consumers never use a certain dosage form of nasal/expectorant drugs

Price:

Pharmacists survey - RUR 25 000 (exempt from VAT) per city (1 segment)

End consumer survey - RUR 25 500 (exempt from VAT) per city (1 segment)

Full report (1 segment) - RUR 102 000 (exempt from VAT)

Full report (2 segments: nasal and expectorant drugs) - RUR 200 000 (exempt from VAT)




"RMBC"
Analytical studies of the Pharmaceutical Industry. 1996-2008. All rights reserved.